Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 1.00 |
| ▸ | LPL | P06858 | 12/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | F11 | P03951 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10323 | 0.94 | LPL (0.88) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL23988523 | 0.90 | LIPG (0.81) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL24336584 | 0.90 | LIPG (0.81) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL2707320 | 0.89 | LIPG (0.83) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL24608995 | 0.89 | LIPG (0.83) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL21042549 | 0.87 | LIPG (0.76) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL26549481 | 0.85 | LIPG (0.73) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL26549551 | 0.84 | LIPG (0.71) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL12681706 | 0.83 | LIPG (0.74) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL28389622 | 0.83 | LIPG (0.88) | LIPGLPLCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11844273-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11844273-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| EP-3418272-B1 | TRIAZINE COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2023-08-30 | — | — | EP | disclosed |
| US-11563183-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-24 | — | — | US | disclosed |
| US-11563183-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-24 | — | — | US | disclosed |
| EP-3590925-B1 | PYRIDINE COMPOUNDS AND THE USES THEREOF | PURDUE PHARMA LP (US) | 2022-03-30 | — | — | EP | disclosed |
| US-20210367158-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-25 | — | — | US | disclosed |
| US-11088331-B2 | — | — | 2021-08-10 | — | — | US | disclosed |
| US-11088331-B2 | — | — | 2021-08-10 | — | — | US | disclosed |
| US-20180375028-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-12-27 | — | — | US | disclosed |
| EP-3418272-A1 | TRIAZINE COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2018-12-26 | — | — | EP | disclosed |
| US-9611222-B2 | Pyridine compounds and the uses thereof | PURDUE PHARMA L.P. (US) | 2017-04-04 | — | — | US | disclosed |
| US-9382243-B2 | Azabenzimidazole tetrahydropyran derivatives | MERCK SHARP & DOHME CORP. (US) | 2016-07-05 | — | — | US | disclosed |
| US-20150259293-A1 | PYRIDINE COMPOUNDS AND THE USES THEREOF | PURDUE PHARMA L.P. | 2015-09-17 | — | — | US | disclosed |
| US-20150210685-A1 | NOVEL AZABENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES | MERCK SHARP & DOHME LLC | 2015-07-30 | — | — | US | disclosed |
| US-9056832-B2 | Pyridine compounds and the users thereof | PURDUE PHARMA L.P. (US) | 2015-06-16 | — | — | US | disclosed |
| US-20130303526-A1 | Pyridine Compounds and the Uses Thereof | PURDUE PHARMA L.P. (US) | 2013-11-14 | — | — | US | disclosed |
| EP-2616441-A2 | PYRIDINE COMPOUNDS AND THE USES THEREOF | Purdue Pharma LP (US) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012035421-A2 | PYRIDINE COMPOUNDS AND THE USES THEREOF | PURDUE PHARMA L.P. (US) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180375028-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | DDT, PPOX, LEF1 | LIPG 3644/4885LPL 3406/4885CA1 2651/4885 |
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | LIPG 2567/4885LPL 2737/4885CA1 386/4885 |
| US-11563183-B2 | Heterocyclic compound and organic light-emitting device including the same | DDT, PPOX, LEF1 | LIPG 3644/4885LPL 3406/4885CA1 2651/4885 |
| US-11844273-B2 | Heterocyclic compound and organic light-emitting device including the same | DDT, PPOX, LEF1 | LIPG 3644/4885LPL 3406/4885CA1 2651/4885 |
| US-20150259293-A1 | PYRIDINE COMPOUNDS AND THE USES THEREOF | TRPV1, CACNA1A, KCNA1 | LIPG 4458/4885LPL 3996/4885CA1 507/4885 |
| US-20150210685-A1 | NOVEL AZABENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES | PRKAG2, PRKAB2, PRKAG1 | LIPG 415/4885LPL 708/4885CA1 4878/4885 |
| US-11088331-B2 | — | DDT, PPOX, DBF4 | LIPG 3975/4885LPL 3891/4885CA1 2348/4885 |
| US-20130303526-A1 | Pyridine Compounds and the Uses Thereof | TRPV1, CACNA1A, KCNA1 | LIPG 4458/4885LPL 3996/4885CA1 507/4885 |
| US-20210367158-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | DDT, PPOX, LEF1 | LIPG 3644/4885LPL 3406/4885CA1 2651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.